Meridian Bioscience, Inc.(VIVO)

Meridian Bioscience, Inc. is a life science company. The Company’s principal businesses are the development, manufacture, sale and distribution of diagnostic test kits, primarily for certain respiratory, gastrointestinal, viral and parasitic infectious diseases; the manufacture and distribution of bulk antigens, antibodies, and reagents used by researchers and other diagnostic manufacturers, and the contract development and manufacture of proteins and other biologicals for use by biopharmaceutical and biotechnology companies engaged in research for new drugs and vaccines. The Company operates in three business segments: US Diagnostics, European Diagnostics and Life Science.
Current Key Statistics:
http://finance.yahoo.com/q/ks?s=VIVO

Reasons to Buy:
- NPM 22% in the year 2009
- Company is improving product mix to improve prrofitablity next year
- Steady growth of 10% per annum for last three years

Reasons to Sell:
- Stock corrected 15%, near 52 week low in March due to lower guidance

Analyst:
Manoj Mohta is an MBA Candidate at the Weatherhead School of Management, Case Western Reserve University and currently working with Philips Healthcare. He has 12 years of work experience in Customer support, marketing and sales especially in automobiles and petroleum retail businesses.

Sources :
http://www.google.com/finance?q=NASDAQ%3AVIVO